The Cannigma
MAY 13, 2022
There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. Made from oil extracted from camphor trees, camphor oil is a common ingredient in topical pain relief products. 12 Pinene had the ability to meditate chemical responses to inflammation in rodent trials.
The Cannigma
JUNE 15, 2021
Charlotte’s story was featured on CNN in 2013 and millions of people saw with their own eyes how a few drops of cannabis oil succeeded where no other epilepsy treatment had —- reducing her seizures from 300 each week to less than three a month. CBD extraction methods. Shutterstock).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 9, 2019
Research has found cannabis can help those diagnosed with either type 1 or 2 diabetes, and those who suffer complications, and a landmark study published in the American Journal of Medicine in 2013 said marijuana compounds can also help control blood sugar. Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment.
Green Relief
MAY 13, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. But CB1 proved to be a tricky target.
Alchimia
OCTOBER 15, 2021
For example, in a 2013 study, the smokers who used a CBD inhaler reduced the number of cigarettes they smoked each day by 40%. A study published in the journal FEBS Letters found that CBD extract could increase wakefulness and reduce rapid eye movement (REM) during sleep.
Green Relief
MAY 12, 2018
As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. In 2013, the International Journal of Molecular Science reported on how TBI is affected by diurnal variations of the endocannabinoid system. But CB1 proved to be a tricky target.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.
Expert insights. Personalized for you.
111 
Let's personalize your content